🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Nuestros expertos debaten sobre primera línea de tratamiento en #cáncerdevejiga y el porcentaje de pacientes que llegan a realizar mantenimiento con Avelumab tras quimioterapia. SEOM SEOR.es SOG-Galicia ESMO - Eur. Oncology Sociedad Mexicana de Oncología, A.C. Urooncologia.arg RAEU - Spanish Urology Residents Working Group European Association of Urology (EAU) SOGUG

Con muchas ganas de debatir sobre las últimas novedades en cáncer urotelial☄️ Os esperamos mañana en nuestro " Hot topics and daily challenges in urothelial cancer" Inscribete aquí🖊️ acrobat.adobe.com/id/urn:aaid:sc…

El Mentorship Research Group de GUARD Consortium lanza el Programa de Mentorización para jóvenes investigadores. Es tu oportunidad para desarrollar un proyecto de investigación dentro de GUARD Consortium, ¡te esperamos! Más información aquí: form.jotform.com/243172342980355

Big news👋. A positive R3 trial for PD-1 in NMIBC! The CREST trial evaluated sasanlimab (PD-1i)+BCG vs Standard BCG (induction and maintenance) in BCG-naïve, high-risk NMIBC.The study met its primary endpoint of EFS with ‘clinically meaningful’ results. pfizer.com/news/press-rel…

Day One #OncoAlertColloquium 🚨STARTS TODAY 12 noon EST🇺🇸 6PM CET🇪🇺 REGISTER for FREE HERE👉 buff.ly/40zeLhq To Accèss the Videos and the LIVE chat with the Experts, you will need a link and password which will be provided upon registration. Todays Schedule: (we

Day One #OncoAlertColloquium 🚨REGISTER for FREE HERE👉 buff.ly/3WIXSju Elena Sevillano M.D. PhD 🇪🇸 of GUARD Consortium Covering Landcape changing Trials in #KidneyCancer REGISTER NOW for a Live chat with Dr. Sevillano In 2024, key kidney cancer trials brought significant

Parece que en esto hay consenso: 🗣 ¿Es posible la curación en cáncer urotelial metastásico? 💬 Con base en los datos EV-103 y EV-302, los 4 ponentes coinciden. #BladderCancer #GUTrends25 Tom Powles Ignacio Duran Elena Sevillano M.D. PhD Roberto Iacovelli Uromigos OncoAlert Oncobites.tv

Un honor haber organizado la 6ª Reunión Anual de Carcinoma Urotelial, con la participación de grandes especialistas. Gracias a ponentes, colaboradores y asistentes por su valiosa presencia. #Urotelial #Oncología #CursoAnualdeUC #Colaboración #FormaciónMédica

🎉 Proud to present our SASAN-SPARING phase 2 trial poster today at #ASCO25! A novel bladder-sparing strategy using sasanlimab as maintenance after neoadjuvant chemo in MIBC. Integrating ctDNA, utDNA, and multi-omic biomarkers to personalize treatment and save bladders

Elena Sevillano M.D. PhD Guillermo de Velasco Juanfran RM Jesus Garcia-Donas Félix Guerrero-Ramos Arantzazu Barquin Garcia Congratulations on making this investigator-initiated study a reality! A well-designed trial with strong translational science. Looking forward to the insights it will bring. Most importantly, it offers hope for patients seeking a bladder-sparing approach. Well done!

Proud of my co-worker Elena Sevillano M.D. PhD, hard work pays off 👏

Happy to be co-lead the SASAN-SPARING phase 2 trial with Elena Sevillano M.D. PhD presented at #ASCO25! A bladder-sparing approach using sasanlimab post-neoadjuvant cisplatin in MIBC. First 16 patients enrolled — stay tuned, results coming soon! #BladderCancer #Immunotherapy

Congratulations Elena Sevillano M.D. PhD Guillermo de Velasco et al. for this really elegant trial! Looking forward to more data :-)

Trials-in-progress – sasanlimab as bladder-sparing maintenance treatment after neoadjuvant chemotherapy in patients with MIBC: The phase 2, SASAN-SPARING trial. Presentation by Elena Sevillano M.D. PhD. #ASCO25 written coverage by Rashid K. Sayyid > bit.ly/3SC4r4S

SASAN-SPARING trial: Bladder-sparing approach for muscle-invasive #BladderCancer. Elena Sevillano M.D. PhD joins Zach Klaassen Georgia Cancer Center to discuss alternatives to radical cystectomy given its significant impact on patients' urinary, bowel, and sexual function, noting that some patients